Fullscreen
Loading...
 
CYTOPATHNET: Online Resource for Cytopathology > GYN Guidelines Non-USA

GYN Guidelines Non-USA

European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology,(Cytopathology 2007, 18, 213–219)(external link)

The European guidelines for quality assurance in cervical cancer screening "...provides a framework that will allow different terminologies and languages to be translated into standard terminology based on the Bethesda system (TBS) for cytology while retaining the cervical intraepithelial neoplasia (CIN) classification for histology. This approach has followed extensive consultation with representatives of many countries and professional groups as well as a discussion forum published in Cytopathology (2005;16:113).

Additional references:
Jordan, J., Arbyn, M., Martin-Hirsch?, P., Schenck, U., Baldauf, J.-J., Da Silva, D., Anttila, A., Nieminen, P. and Prendiville, W. (2008), European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1. Cytopathology, 19: 342–354. doi:10.1111/j.1365-2303.2008.00623.x(external link)

Table 1
Classification of Munich (II), modified by Soost in 1989 5.

ClassCytological descriptionRecommendation
I Normal cells
II Regenerative cells, immature metaplastic cells, important degenerative or inflammatory changes, para- and hyperkeratinizing cells. Normal endometrial cells even after the menopause. cytological control if necessary (with or without anti-inflammatory or hormonal treatment)
III Important degenerative, iatrogenic or inflammatory changes of the cells where benignity or malignancy cannot be diagnosed with certainty even if the smear is adequately prepared. short-term cytological control if necessary after anti-inflammatory or hormonal treatment, or immediate histological control
IIID Mild to moderate dysplasia (CIN I and II) cytological control in 3 months
IIIG Abnormal cells of the glandular epithelium whose carcinomatous nature cannot be excluded with certainty; if possible with an indication of the endometrial, endocervical or extra-uterine origin of the cells. cytological or histological control
IVa Severe dysplasia or carcinoma in situ (CIN III) histological control
IVbSevere dysplasia or carcinoma in situ; invasive carcinoma not excluded histological control
VInvasive epidermoid carcinoma of the uterine cervix; adenocarcinoma, indicating if possible the endometrial, endocervical or extra-uterine origin of the cells. Other malignant tumours histological control

 


Contributors to this page: admin .
Page last modified on Sunday 22 of April, 2012 09:36:39 MDT by admin.
The content on this page is licensed under the terms of the Creative Commons Attribution-ShareAlike License.

Search Wiki Page

Exact match

CYTOPATHNET Polls

Do you plan to adopt the Bethesda Guidelines for Thyroid Cytology?






Code of Conduct

We comply with the HONcode standard for health trust worthy information:
verify here.

Theme: Tikinewt

TikiWiki assistant

Thank you for installing Tikiwiki!

LoginTo begin configuring Tiki, please login as admin.

The Tikiwiki CommunityTo learn more, visit: http://tiki.org.

Tikiwiki DocumentationFor help, visit http://doc.tiki.org.

Upcoming events

1)  Tue 12 of May, 2015
National Cytotechnology Day

Online users

98 online users

Search PubMed

PubMed Logo
Search PubMed:   

Shoutbox

kucingz2 points , 02:08 MDT, Tue 06 of May, 2014: http://goo.gl/3n9rax
kucingz2 points , 01:52 MDT, Mon 21 of Apr., 2014: [Link] [Link] [Link] [Link] [Link]
admin, 21:24 MST, Wed 22 of Feb., 2012: User registration enhancements made and more coming in future.
admin, 18:06 MST, Sun 29 of Jan., 2012: Site upgraded from 6.4 to 6.6.
admin, 21:56 MDT, Thu 06 of Oct., 2011: Not sure I totally understand question. Perhaps post to forums for feedback.

Random Image

thumbnail
hsil_CIN3_tp_092602_03.jpg
Gallery: Gynecologic (GYN) Cytology

Google Search

 
cytopathnet.org
WWW

Site Language: English